Crowdfunding for Health Startups: A Masterclass

Why we picked this episode

Every week the HTC editorial desk listens across the health tech podcast landscape and selects the conversations that actually move a listener's understanding forward. This episode of StartUp Health NOW, featuring Jim Iversen, earned its place on that list.

What the conversation covers

How one founder raised over $3 million via crowdfunding - which platforms suit health startups, and creative incentives like fractional patent royalties.

Key discussion threads

The bigger picture

The AI adoption question runs through every executive conversation in 2026. The evidence base is finally arriving: the largest controlled study of ambient documentation, published in JAMA, found clinicians saved 16 minutes of documentation time per day - but only a third of users hit the usage threshold for maximum benefit (our coverage). Meanwhile Rock Health has stopped labeling AI as a differentiator at all, because every company claims it - which is exactly why operating discipline of the kind described here separates winners from demo-ware.

The capital context matters here. US digital health raised $7.4 billion in H1 2026 with 45% of it concentrated in $100M+ megadeals, and 115 acquisitions made it the busiest M&A run since 2021 (our analysis). In a market this concentrated, the strategies described in this conversation - defensible data, measurable outcomes, disciplined growth - are precisely what separates the funded from the folded.

The HTC take

Listen with a notebook handy: the most valuable material here is operational, not theoretical - the kind of detail that only surfaces when practitioners talk shop. Pair it with our related coverage below and you have a working brief on the topic.